February 7, 2018 / 12:09 PM / 2 months ago

BRIEF-Keryx Biopharmaceuticals Q4 Loss Per Share $0.26

Feb 7 (Reuters) - Keryx Biopharmaceuticals Inc:

* KERYX BIOPHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

* Q4 REVENUE $18.7 MILLION VERSUS $9.5 MILLION

* CASH AND CASH EQUIVALENTS AS OF DEC 31, 2017 TOTALED ABOUT $93.5 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below